Chicago-based Northwestern Medicine recorded an operating income of $166 million (5.4% operating margin) in the first quarter of fiscal 2026, up from an operating income of $135.5 million (5.2% operating margin) during the same period last year, according to its Jan. 16 financial report.
Northwestern Medicine posted revenue of $3.1 billion for the three months ended Nov. 30, up from $2.6 billion during the same period last year. Patient service revenue was $2.8 billion, up from $2.4 billion.
Total operating expenses were $2.9 billion in the first quarter of 2026, up from $2.5 billion last year. Salaries and employee benefits totaled $1.4 billion, up from $1.2 billion. Supply expenses totaled $727.2 million, up from $623.8 million.
After accounting for nonoperating items, such as investment returns, Northwestern reported a net income of $394.7 million in the first quarter of 2026, up from $377.4 million recorded during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
